Dhananjay Singh takes up role of Managing Director at Merck Life Sciences in India, as reported by ET HealthWorld

Merck, a leading pharmaceutical company, has appointed Dhananjay Singh as the Managing Director of Merck Life Science in India, effective April 1, 2024. Singh will be taking over from Sreenath NS, who is retiring after 36 years of service with Merck in India. With 26 years of experience at Merck, Singh has played a crucial role in shaping the Science and Lab Solutions commercial business in India.

As the Managing Director, Singh will be responsible for driving the Life Science strategy in India, ensuring governance and compliance, and collaborating with other leaders from Merck’s businesses in India. Singh’s expertise in market dynamics and multi-stakeholder relationship management is expected to strengthen Merck Life Science’s position in the Indian market.

Having joined Sigma-Aldrich in 1997, Singh has held various leadership roles in commercial organizations before his appointment as the Head of Science & Lab Solutions Commercial for India in 2022. Singh expressed his commitment to meeting customers’ demands through strategic focus and partnerships, aiming for unparalleled success in navigating the life sciences industry in India.

Pratima Reddy, the Country Speaker of Merck India, praised Singh for his dedication to advancing scientific progress in collaboration with customers and expressed optimism about his leadership in shaping India’s narrative towards performance and progress. The appointment of Dhananjay Singh as the Managing Director of Merck Life Science in India signifies a new chapter in the company’s commitment to innovation and growth in the Indian market.